Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Puma Biotechnology (PBYI) Net Income (2017 - 2025)

Historic Net Income for Puma Biotechnology (PBYI) over the last 9 years, with Q3 2025 value amounting to $8.8 million.

  • Puma Biotechnology's Net Income fell 5647.0% to $8.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $29.9 million, marking a year-over-year increase of 2866.49%. This contributed to the annual value of $23.2 million for FY2024, which is 746.61% up from last year.
  • According to the latest figures from Q3 2025, Puma Biotechnology's Net Income is $8.8 million, which was down 5647.0% from $5.9 million recorded in Q2 2025.
  • In the past 5 years, Puma Biotechnology's Net Income ranged from a high of $20.3 million in Q3 2024 and a low of -$44.7 million during Q3 2021
  • Over the past 5 years, Puma Biotechnology's median Net Income value was $3.0 million (recorded in 2025), while the average stood at $1.8 million.
  • In the last 5 years, Puma Biotechnology's Net Income surged by 171000.0% in 2023 and then tumbled by 44368.31% in 2024.
  • Over the past 5 years, Puma Biotechnology's Net Income (Quarter) stood at $4.2 million in 2021, then crashed by 232.72% to -$5.6 million in 2022, then skyrocketed by 318.84% to $12.3 million in 2023, then decreased by 0.31% to $12.2 million in 2024, then fell by 27.69% to $8.8 million in 2025.
  • Its Net Income stands at $8.8 million for Q3 2025, versus $5.9 million for Q2 2025 and $3.0 million for Q1 2025.